New phase 1 SURPASS trial cohort: Early-line ADP-A2M4CD8 T-cell receptor T-cell therapy plus pembrolizumab in urothelial carcinoma.
| Autor: | Aggen, David H, Garcia, Alejandro, Saro Suarez, Jose M, Sauer, Amy, Cristiani, Sebastiano, Brophy, Francine Elizabeth, Streets, Sharon, Norry, Elliot, Nelson, Ariel Ann, Kilari, Deepak, Garmezy, Benjamin, Charlson, John A., Zugazagoitia, Jon, Calvo, Emiliano, Moreno, Irene, Moreno, Victor, Hoimes, Christopher J., Hong, David S., Cervantes, Andres |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, pTPS708-TPS708, 193p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|